Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record is now available, showing the study’s treatment approach, eligibility criteria, recruitment status, locations, and outcome measures. It also includes study history, collaborators, and protocol documents.
    Difference
    74%
    Check dated 2026-11-08T11:43:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:33:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning terminology from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T12:35:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:07:40.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:50:35.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and indicating an access/permissions issue. The surrounding site chrome remains visible, showing this is an error state rather than new study information.
    Difference
    23%
    Check dated 2026-09-20T11:26:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.